Tychon® introduces PARs®, which harnesses the power of protein dimerization to produce chemically self-assembling nanorings (CSANs). These nanorings form a stable, flexible construct to combine a patient’s T lymphocytes (T-cells) and a host of cancer-seeking antigens, creating a wide variety of adoptive cell therapies (PARs®) with selective anti-tumor capabilities.
To create a viable
alternative to surgery,
radiation & chemotherapy.
+1 612 200 1039
807 Broadway St NE, Ste 350, Minneapolis, MN 55413